Defining a renal anemia management period
- 1 December 2000
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 36 (6), S13-S23
- https://doi.org/10.1053/ajkd.2000.19927
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobinAmerican Journal of Kidney Diseases, 1999
- Effect of Serum Parathyroid Hormone and Bone Marrow Fibrosis on the Response to Erythropoietin in UremiaNew England Journal of Medicine, 1993
- A comparison of the responses to recombinant human erythropoietin in normal and uremic subjectsKidney International, 1992
- Effectiveness and Safety of Recombinant Human Erythropoietin in Predialysis PatientsNephron, 1992
- Erythropoietin deficiency in acute tubular necrosisJournal of Internal Medicine, 1990
- Outcome of Congestive Heart Failure, Dilated Cardiomyopathy, Hypertrophic Hyperkinetic Disease, and Ischemic Heart Disease in Dialysis PatientsAmerican Journal of Nephrology, 1990
- Impact of left ventricular hypertrophy on survival in end-stage renal diseaseKidney International, 1989
- Treatment of the Anemia of Progressive Renal Failure with Recombinant Human ErythropoietinNew England Journal of Medicine, 1989
- Use of Water‐Soluble Vitamins in Patients with Chronic Renal. FailureSeminars in Dialysis, 1988
- Relationships between platelet function tests in normal and uraemic subjectsJournal of Clinical Pathology, 1970